Control of in vitro and in vivo spread of coxsackievirus B4 infection by sensitized spleen cells and antibody.
D000362:Agar; D000818:Animals; D000914:Antibodies, Viral; D000961:Antilymphocyte Serum / Q000494:pharmacology; D002448:Cell Adhesion; D003384:Coxsackievirus Infections / Q000517:prevention & control*; D003470:Culture Media; D007106:Immune Sera / Q000494:pharmacology; D007116:Immunization, Passive; D007074:Immunoglobulin G; D051379:Mice; D013154:Spleen / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology; D010948:Viral Plaque Assay
D000914:Antibodies, Viral; D000961:Antilymphocyte Serum; D003470:Culture Media; D007106:Immune Sera; D007074:Immunoglobulin G; D000362:Agar